Dehydrojuncusol TN3809
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.
CAS nr:
117824-04-1
Purity:
98%
Molecular Weight:
264,3
SMILES:
Cc1c(O)cc2ccc3c(C)c(O)ccc3c2c1C=C
Formula:
C18H16O2
Pathway:
Microbiology/Virology,Proteases/Proteasome
Target:
HCV Protease,HCV Protease
